» Articles » PMID: 15123616

Crystal Structure of the Toll/interleukin-1 Receptor Domain of Human IL-1RAPL

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 May 5
PMID 15123616
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The Toll/interleukin-1 receptor (TIR) domain is conserved in the intracellular regions of Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs) as well as in several cytoplasmic adapter molecules. This domain has crucial roles in signal transduction by these receptors for host immune response. Here we report the crystal structure at 2.3-A resolution of the TIR domain of human IL-1RAPL, the first structure of a TIR domain of the IL-1R superfamily. There are large structural differences between this TIR domain and that of TLR1 and TLR2. Helix alphaD in IL-1RAPL is almost perpendicular to its equivalent in TLR1 or TLR2. The BB loop contains a hydrogen bond unique to IL-1RAPL between Thr residues at the 8th and 10th positions. The structural and sequence diversity among these domains may be important for specificity in the signal transduction by these receptors. A dimer of the TIR domain of IL-1RAPL is observed in the crystal, although this domain is monomeric in solution. Residues in the dimer interface are mostly unique to IL-1RAPL, which is consistent with the distinct functional roles of this receptor. Our functional studies show IL-1RAPL can activate JNK but not the ERK or the p38 MAP kinases, whereas its close homolog, TIGIRR, cannot activate JNK. Deletion mutagenesis studies show that the activation of JNK by IL-1RAPL does not depend on the integrity of its TIR domain, suggesting a distinct mechanism of signaling through this receptor.

Citing Articles

Structural characterization of TIR-domain signalosomes through a combination of structural biology approaches.

Bhatt A, Mishra B, Gu W, Sorbello M, Xu H, Ve T IUCrJ. 2024; 11(Pt 5):695-707.

PMID: 39190506 PMC: 11364022. DOI: 10.1107/S2052252524007693.


Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders.

Haghshenas M, Zamir M, Sadeghi M, Fattahi M, Mirshekari K, Ghaderi A Eur Cytokine Netw. 2023; 33(3):54-69.

PMID: 37052152 PMC: 10134710. DOI: 10.1684/ecn.2022.0480.


Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3.

The E, de Graaf D, Zhai Y, Yao Q, Ao L, Fullerton D Proc Natl Acad Sci U S A. 2022; 119(36):e2202577119.

PMID: 36037361 PMC: 9457240. DOI: 10.1073/pnas.2202577119.


Structural basis of the IL-1 receptor TIR domain-mediated IL-1 signaling.

Zhou J, Xiao Y, Ren Y, Ge J, Wang X iScience. 2022; 25(7):104508.

PMID: 35754719 PMC: 9213720. DOI: 10.1016/j.isci.2022.104508.


What Is IL-1 for? The Functions of Interleukin-1 Across Evolution.

Boraschi D Front Immunol. 2022; 13:872155.

PMID: 35464444 PMC: 9020223. DOI: 10.3389/fimmu.2022.872155.